Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
DaVita Inc. brinda servicios de diálisis renal para pacientes que padecen insuficiencia renal crónica en los Estados Unidos. La empresa opera centros de diálisis renal y brinda servicios de laboratorio relacionados en centros de diálisis para pacientes ambulatorios.
Traducido automáticamente
Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →
| Cuenta de resultados | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos totales | $13.8B | $13.6B | $12.8B | $12.1B | $11.6B | $11.6B | $11.6B | $11.4B | $11.4B | $10.9B | $14.7B | $13.8B | $12.8B | $11.8B | $8.2B | $6.8B | $6.4B | $6.1B | $5.7B | $5.3B | $4.9B |
| Beneficio bruto | $4.3B | $3.7B | $4.2B | $3.8B | $3.4B | $3.6B | $3.6B | $3.5B | $3.2B | $3.2B | $3.3B | $3.1B | $3.7B | $3.6B | $2.6B | $2.1B | $1.8B | $1.9B | $1.7B | $1.7B | $1.5B |
| % de margen bruto | 31.1% | 27.0% | 32.9% | 31.5% | 29.3% | 31.4% | 30.8% | 30.5% | 28.1% | 29.8% | 22.2% | 22.7% | 28.7% | 30.3% | 31.8% | 30.9% | 27.8% | 30.4% | 30.7% | 31.8% | 30.5% |
| Ingresos operativos (EBIT) | $2.1B | $2.0B | $2.1B | $1.6B | $1.3B | $1.8B | $1.7B | $1.6B | $1.5B | $1.8B | $2.0B | $1.1B | $1.8B | $1.6B | $1.3B | $1.2B | $994M | $940M | $869M | $862M | $739M |
| % de margen operativo | 15.0% | 14.7% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | 16.7% | 13.8% | 8.2% | 14.2% | 13.2% | 15.8% | 17.0% | 15.4% | 15.4% | 15.3% | 16.4% | 15.2% |
| Ingresos netos | $781M | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | $270M | $723M | $633M | $536M | $478M | $406M | $423M | $374M | $382M | $290M |
| % de margen neto | 5.7% | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | 6.1% | 6.0% | 2.0% | 5.7% | 5.4% | 6.6% | 7.0% | 6.3% | 6.9% | 6.6% | 7.2% | 5.9% |
| EBITDA | $2.7B | $2.6B | $2.7B | $2.3B | $2.1B | $2.5B | $2.3B | $2.3B | $2.1B | $2.6B | $2.8B | $1.7B | $2.3B | $2.1B | $1.6B | $1.4B | $1.2B | $1.2B | $1.1B | $1.1B | $913M |
| Beneficio por acción (EPS) | $10.14 | $8.48 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | $1.25 | $3.33 | $2.95 | $2.74 | $2.48 | $1.97 | $2.03 | $1.77 | $1.78 | $1.37 |
| Acciones en circulación (M) | 69M | 88M | 87M | 93M | 96M | 110M | 123M | 154M | 172M | 191M | 205M | 216M | 217M | 215M | 196M | 193M | 206M | 208M | 212M | 215M | 212M |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de DVA. /companies/us/DVA
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms